Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 1998 Sep;15(8):469–477. doi: 10.1023/A:1022578303272

Preservation of Fertility in Women Undergoing Chemotherapy: Current Approach and Future Prospects

Ronit Abir 1,, Benjamin Fisch 1, Ahud Raz 1, Shmuel Nitke 1, Zion Ben-Rafael 1
PMCID: PMC3455041  PMID: 9785194

Abstract

Purpose:Anticancer treatment causes ovarian failure.

Methods:Some hormones may have a protective effect on the ovary. Cryopreservation (freezing) of oocytes has had very limited success, and therefore, currently its use before chemotherapy is not a feasible option. However, cryopreservation of embryos is possible. Another solution is oocyte donation followed by in vitro fertilization (IVF).

Results:Ovarian cortical slices containing primordial follicles have been cryopreserved successfully. To restore fertility, cryopreserved–thawed tissue taken from cancer patients before therapy could be replanted after recovery. The possible risk of malignancy restoration could be eliminated by obtaining unilaminar follicles from cryopreserved–thawed tissue and growing them in vitro, followed by routine IVF.

Conclusions:Although women who undergo chemotherapy face limited options for fertility preservation, intensive studies in cryopreservation and in vitro maturation of follicles harbor hope for brighter prospects in the future.

Keywords: primordial follicles, chemotherapy, “protective” hormonal treatment, cryopreservation, in vitro maturation

Full Text

The Full Text of this article is available as a PDF (2.3 MB).

REFERENCES

  • 1.Barlow DH. Premature ovarian failure. Bailliere's Clin Obstet Gynecol. 1996;10:369–384. doi: 10.1016/s0950-3552(96)80020-4. [DOI] [PubMed] [Google Scholar]
  • 2.Chatterjee R, Goldstone AH. Gonadal damage and the effects of fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant. 1996;17:5–11. [PubMed] [Google Scholar]
  • 3.Gougeon A. Regulations of ovarian follicular development in primates: Facts and hypotheses. Endocrine Rev. 1996;17:121–154. doi: 10.1210/edrv-17-2-121. [DOI] [PubMed] [Google Scholar]
  • 4.Ataya KM, McKana JA, Weintraub AM, Clark MR, LeMaire WJ. A luteinising hormone-releasing hormone agonist for the prevention of chemotherapy-induced follicular loss in rats. Cancer Res. 1985;45:3651–3656. [PubMed] [Google Scholar]
  • 5.Ataya K, Moghissi K. Chemotherapy-induced premature ovarian failure: mechanism and prevention. Steroids. 1989;54:607–626. doi: 10.1016/0039-128x(89)90084-6. [DOI] [PubMed] [Google Scholar]
  • 6.Ataya KM, Pyden E, Sacco A. Effect of “activated” cyclophosphamide on mouse oocyte in vitro fertilization and cleavage. Reprod Toxicol. 1988;2:105–109. doi: 10.1016/0890-6238(88)90005-6. [DOI] [PubMed] [Google Scholar]
  • 7.Ramahi-Ataya A, Ataya KM, Subramanian M, Sturck R. The effect of “activated” cyclophosphamide on rat granulosa cells in vitro. Reprod Toxicol. 1988;2:99–103. doi: 10.1016/0890-6238(88)90004-4. [DOI] [PubMed] [Google Scholar]
  • 8.Nicosia SV, Matus-Ridley M, Meadows AT. Gonadal effects of cancer therapy in girls. Cancer. 1985;55:2364–2372. doi: 10.1002/1097-0142(19850515)55:10<2364::aid-cncr2820551011>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  • 9.Marcello MF, Nucifero G, Romeo R, Dino GD, Russo I, Russo A, Palumbo G, Schiliro G. Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer. 1990;66:2099–2104. doi: 10.1002/1097-0142(19901115)66:10<2099::aid-cncr2820661010>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  • 10.Owens S, Roberts WS, Fiorica JV, Hoffman MS, Lapolla JP, Cavanagh D. Ovarian management at the time of radical hysterectomy for cancer of the cervix. Gynecol Oncol. 1989;35:349–351. doi: 10.1016/0090-8258(89)90077-2. [DOI] [PubMed] [Google Scholar]
  • 11.van Beurden M, Schuster Uitterhoeve AL, Lemmes FB. Feasibility of transportation of the ovaries in the surgical and radiotherapeutical treatment of cervical cancer. Eur J Surg Oncol. 1990;16:141–146. [PubMed] [Google Scholar]
  • 12.Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol. 1995;56:3–7. doi: 10.1006/gyno.1995.1002. [DOI] [PubMed] [Google Scholar]
  • 13.Chapman RM, Sutcliffe SB. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood. 1991;58:849–851. [PubMed] [Google Scholar]
  • 14.Chapman RM, Sutcliffe SB, Malpass JS. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA. 1979;242:1788–1881. [PubMed] [Google Scholar]
  • 15.Blumenfeld Z, Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med. 1997;29:199–206. doi: 10.3109/07853899708999337. [DOI] [PubMed] [Google Scholar]
  • 16.Montz FJ, Wolff AJ, Gambone JC. Gonadal protection and fecundity rates in cyclophosphamide-treated rats. Cancer Res. 1991;51:2124–2126. [PubMed] [Google Scholar]
  • 17.Ataya K, Rao LV, Lawrence E, Kimmel R. Hormone-releasing agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod. 1995;52:365–372. doi: 10.1095/biolreprod52.2.365. [DOI] [PubMed] [Google Scholar]
  • 18.Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel with chemotherapy. Hum Reprod. 1996;11:1620–1626. doi: 10.1093/oxfordjournals.humrep.a019457. [DOI] [PubMed] [Google Scholar]
  • 19.Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination of chemotherapy for Hodgkin's disease. Hum Reprod. 1993;8:2080–2087. doi: 10.1093/oxfordjournals.humrep.a137985. [DOI] [PubMed] [Google Scholar]
  • 20.Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmatic sperm injection to cryopreserved human oocytes. Fertil Steril. 1997;68:724–726. doi: 10.1016/s0015-0282(97)00268-9. [DOI] [PubMed] [Google Scholar]
  • 21.Bernard A, Fuller BJ. Cryopreservation of human oocytes: A review of current problems and perspectives. Hum Reprod Update. 1996;2:193–207. doi: 10.1093/humupd/2.3.193. [DOI] [PubMed] [Google Scholar]
  • 22.Gook DA, Osborn SM, Johnson WIH. Parthogenic activity of human oocytes following cryopreservation using 1,2-propandiol. Hum Reprod. 1995;10:654–658. doi: 10.1093/oxfordjournals.humrep.a136005. [DOI] [PubMed] [Google Scholar]
  • 23.Al-Hasani S, Diedrich K, van der Ven H, Reinecke A, Hartje M, Krebs D. Cryopreservation of human oocytes. Hum Reprod. 1987;2:695–700. doi: 10.1093/oxfordjournals.humrep.a136616. [DOI] [PubMed] [Google Scholar]
  • 24.Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1:884–886. doi: 10.1016/s0140-6736(86)90989-x. [DOI] [PubMed] [Google Scholar]
  • 25.Van Uem JFHM, Siebzehnruebl ER, Schuh B, Koch R, Trontow S, Lang N. Birth after cryopreservation of unfertilised oocytes. Lancet. 1987;1:752–753. doi: 10.1016/s0140-6736(87)90398-9. [DOI] [PubMed] [Google Scholar]
  • 26.Tucker M, Wright G, Morton P, Shanguo L, Massey J, Kort H. Preliminary experience with human oocye cryopreservation using 1,2-propanediol and sucrose. Hum Reprod. 1996;7:1513–1515. doi: 10.1093/oxfordjournals.humrep.a019428. [DOI] [PubMed] [Google Scholar]
  • 27.Gook DA, Schiewe MC, Osborn SM, Asch R, Jansen RPS, Johnson WIH. Intracytoplasmic sperm injection and embryo development of human crypreserved using 1,2-propandiol. Human Reprod. 1995;10:2637–2641. doi: 10.1093/oxfordjournals.humrep.a135759. [DOI] [PubMed] [Google Scholar]
  • 28.Kazem R, Thompson LA, Laing MA, Hamilton MPR, Templeton A. Cryopreservation of human oocytes and fertilization by two techniques: in vitro fertilization and intra cytoplasmic sperm injection. Hum Reprod. 1995;10:2650–2654. doi: 10.1093/oxfordjournals.humrep.a135761. [DOI] [PubMed] [Google Scholar]
  • 29.Candy CJ, Wood MJ, Whittingham DG, Merriman JA, Choundhury N. Cryopreservation of immature mouse oocytes. Hum Reprod. 1994;9:1738–1742. doi: 10.1093/oxfordjournals.humrep.a138785. [DOI] [PubMed] [Google Scholar]
  • 30.Toth TL, Baka SG, Veeck LL, Jones HW, Muasher S, Lanzendorf SE. Fertilization and in vitro development of cryopreserved prophase I oocytes. Fertil Steril. 1994;61:891–894. doi: 10.1016/s0015-0282(16)56702-8. [DOI] [PubMed] [Google Scholar]
  • 31.Son WY, Park SE, Lee KA, Lee WS, Ko JJ, Yoon TK, Cha KY. Effects of 1,2 propandiol and freezing-thawing on the in vitro development capacity of human immature oocytes. Fertil Steril. 1996;66:995–999. doi: 10.1016/s0015-0282(16)58696-8. [DOI] [PubMed] [Google Scholar]
  • 32.Toth TL, Lanzendorf SE, Sandow BA, Veeck LL, Hassen WA, Hodgen GD. Cryopreservation of human prophase I oocytes collected from unstimulated cycles. Fertil Steril. 1994;61:1077–1082. [PubMed] [Google Scholar]
  • 33.Gelety T, Surrey E. Cryopreservation of embryos and oocytes: an update. Curr Opin Obstet Gynecol. 1993;5:606–614. [PubMed] [Google Scholar]
  • 34.Brown JR, Modell E, Obasaju M, Ying YK. Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast. Hum Reprod. 1996;11:197–199. doi: 10.1093/oxfordjournals.humrep.a019017. [DOI] [PubMed] [Google Scholar]
  • 35.Morris R, Sauer M. New advances in the treatment of fertility in women with ovarian failure. Curr Opin Obstet Gynecol. 1993;5:368–377. [PubMed] [Google Scholar]
  • 36.Rio B, Letur-Konirsch H, Ajechenbaum-Cymbalista F, Bauduer F, De-Ziegler D, Pellissier C, Bernadou A, Frydman R, Zittoun R. Full term pregnancy with embryos from donated oocytes in 36-year old woman allografted for chronic myeloid leukaemia. Bone Marrow Transplant. 1994;13:487–488. [PubMed] [Google Scholar]
  • 37.Atkinson HG, Apperley JF, Dawson K, Goldman JM, Winston RM. Successful pregnancy after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Lancet. 1994;344:1994. doi: 10.1016/s0140-6736(94)92804-5. [DOI] [PubMed] [Google Scholar]
  • 38.Shushan A, Schenker JG. The use of oocytes obtained from a aborted fetuses in egg donation programs. Fertil Steril. 1994;62:449–451. doi: 10.1016/s0015-0282(16)56929-5. [DOI] [PubMed] [Google Scholar]
  • 39.Cox S-L, Shaw J, Jenkin G. Transplantation of cryopreserved fetal ovarian tissue to adult recipients in mice. J Reprod Fertil. 1996;107:315–322. doi: 10.1530/jrf.0.1070315. [DOI] [PubMed] [Google Scholar]
  • 40.Wandji S-A, Srsen V, Voss AK, Eppig JJ, Fortune JE. Initiation of in vitro growth of bovine primordial follicles. Biol Reprod. 1996;55:942–948. doi: 10.1095/biolreprod55.5.942. [DOI] [PubMed] [Google Scholar]
  • 41.Wandji S-A, Srsen V, Nathanielsz PW, Eppig JJ, Fortune JE. Initation of growth of baboon primordial follicles in vitro. Hum Reprod. 1997;12:1993–2001. doi: 10.1093/humrep/12.9.1993. [DOI] [PubMed] [Google Scholar]
  • 42.Zhang J, Liu J, Xu KP, Liu B, DiMattina M. Extracorporeal development and ultrarapid freezing of human fetal ova. J Assist Reprod Genet. 1995;12:361–368. doi: 10.1007/BF02215727. [DOI] [PubMed] [Google Scholar]
  • 43.Gosden RG. Oocyte development throughout life. In: Grudzinshes JG, Yovici JL, editors. Gametes—The Oocyte. Cambridge: Cambridge University Press; 1995. pp. 119–149. [Google Scholar]
  • 44.Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autographs stored at −196°C. Hum Reprod. 1994;9:597–603. doi: 10.1093/oxfordjournals.humrep.a138556. [DOI] [PubMed] [Google Scholar]
  • 45.Nugent D, Meirow D, Brook PF, Aubard Y, Gosden RG. Transplantation in reproductive medicine: Previous experience, present knowledge and future prospects. Hum Reprod Update. 1997;3:267–280. doi: 10.1093/humupd/3.3.267. [DOI] [PubMed] [Google Scholar]
  • 46.Gosden RG. Restitution of fertility in sterilised mice by transferring primordial ovarian follicles. Hum Reprod. 1990;5:117–122. doi: 10.1093/oxfordjournals.humrep.a137053. [DOI] [PubMed] [Google Scholar]
  • 47.Gosden RG. Transplantation of ovaries and testes. In: Edwards RG, editor. Fetal Tissue Transplants in Medicine. Cambridge: Cambridge University Press; 1992. pp. 253–279. [Google Scholar]
  • 48.Carroll J, Gosden RG. Transplantation of frozen-thawed mouse primordial follicles. Hum Reprod. 1993;8:1163–1167. doi: 10.1093/oxfordjournals.humrep.a138221. [DOI] [PubMed] [Google Scholar]
  • 49.Guanasena KT, Villines PM, Critser ES, Crister JK. Live births after autologous transplant of cryopreserved mouse ovaries. Hum Reprod. 1997;12:101–106. doi: 10.1093/humrep/12.1.101. [DOI] [PubMed] [Google Scholar]
  • 50.Gosden RG, Boulton MI, Grant K, Webb R. Follicular development from ovarian xenografts in SCID mice. J Reprod Fert. 1994;101:619–623. doi: 10.1530/jrf.0.1010619. [DOI] [PubMed] [Google Scholar]
  • 51.Oktay K, Newton H, Mullan J, Gosden RG. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod. 1998;13:1133–1138. doi: 10.1093/humrep/13.5.1133. [DOI] [PubMed] [Google Scholar]
  • 52.Candy CJ, Wood MJ, Whittingham DG. Follicular development in cryopreserved marmoset ovarian tissue after transplantation. Hum Reprod. 1995;10:2334–2338. doi: 10.1093/oxfordjournals.humrep.a136295. [DOI] [PubMed] [Google Scholar]
  • 53.Hovatta O, Silye R, Kraustz T, Abir R, Margara RA, Trew G, Lass A, Winston RML. Cryopreservation of human ovarian tissue by using dimethylsulphoxide and propandiol-sucrose as cryoprotectants. Hum Reprod. 1996;11:1268–1272. doi: 10.1093/oxfordjournals.humrep.a019370. [DOI] [PubMed] [Google Scholar]
  • 54.Newton H, Aubard Y, Rutherford A, Sharma V, Gosden R. Low temperature storage and grafting of human ovarian tissue. Hum Reprod. 1996;11:1487–1491. doi: 10.1093/oxfordjournals.humrep.a019423. [DOI] [PubMed] [Google Scholar]
  • 55.Newton H, Fisher J, Arnold JRP, Peggy DE, Faddy MJ, Gosden RG. Permeation of human ovarian tissue with cryopretective agents in preparation for cryopreservation. Hum Reprod. 1998;13:376–380. doi: 10.1093/humrep/13.2.376. [DOI] [PubMed] [Google Scholar]
  • 56.Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996;11:1668–1673. doi: 10.1093/oxfordjournals.humrep.a019467. [DOI] [PubMed] [Google Scholar]
  • 57.Shaw J, Trounson A. Oncological implications in the replacement of ovarian tissue. Hum Reprod. 1997;12:403–405. [PubMed] [Google Scholar]
  • 58.Gosden RG, Rutherford AJ, Norfolk DR. Ovarian banking for cancer patients-transmission of malignant cells in ovarian grafts. Hum Reprod. 1997;12:403. doi: 10.1093/humrep/12.3.403. [DOI] [PubMed] [Google Scholar]
  • 59.Moomjy M, Rosenwaks Z. Ovarian tissue cryopreservation the time is now. Transplantation or in vitro maturation: the time awaits. Fertil Steril. 1998;69:999–1000. doi: 10.1016/s0015-0282(98)00091-0. [DOI] [PubMed] [Google Scholar]
  • 60.Gosden RG, Boland NI, Spears N, Murray AA, Chapman M, Wade JC, Zohdy NI, Brown N. The biology of follicular oocyte development in vitro. Reprod Med Rev. 1993;2:129–152. [Google Scholar]
  • 61.Hartshorne GM. In vitro culture of ovarian follicles. Rev Reprod. 1997;2:94–104. doi: 10.1530/ror.0.0020094. [DOI] [PubMed] [Google Scholar]
  • 62.Eppig DG, Schroeder AC. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro. Biol Reprod. 1989;41:268–276. doi: 10.1095/biolreprod41.2.268. [DOI] [PubMed] [Google Scholar]
  • 63.Spears N, Boland NI, Murray AA, Gosden RG. Mouse oocytes derived from in vitro grown primary ovarian follicles are fertile. Hum Reprod. 1994;9:527–532. doi: 10.1093/oxfordjournals.humrep.a138539. [DOI] [PubMed] [Google Scholar]
  • 64.Roy SK, Greenwald GS. Hormonal requirements for the growth and differentiation of hamster preantral follicles in long term culture. J Reprod Fert. 1989;87:103–114. doi: 10.1530/jrf.0.0870103. [DOI] [PubMed] [Google Scholar]
  • 65.Hirao Y, Nagai T, Kubo M, Miyano T, Miyake M, Kato S. In vitro growth of and maturation of pig oocytes. J Reprod Fert. 1994;100:333–339. doi: 10.1530/jrf.0.1000333. [DOI] [PubMed] [Google Scholar]
  • 66.Roy SK, Treacy BJ. Isolation and long term culture of human preantral follicles. Fertil Steril. 1993;59:783–790. [PubMed] [Google Scholar]
  • 67.Abir R, Franks S, Mobberley MA, Moore PA, Margara RA, Winston RML. Mechanical isolation and in vitro growth of preantral and small antral human follicles. Fertil Steril. 1997;68:682–688. doi: 10.1016/s0015-0282(97)00264-1. [DOI] [PubMed] [Google Scholar]
  • 68.Hughesdon PE. Morphology and morphogenesis of the Stein-Leventhal ovary and so-called “hyperthecosis.”. Obstet Gynecol Surv. 1982;37:59–77. doi: 10.1097/00006254-198202000-00001. [DOI] [PubMed] [Google Scholar]
  • 69.Qvist R, Blackwell LF, Bourne H, Brown JB. Development of mouse follicles from primary to preovulatory stages in vitro. J Reprod Fert. 1990;89:169–180. doi: 10.1530/jrf.0.0890169. [DOI] [PubMed] [Google Scholar]
  • 70.Eppig JJ, O'Brien M. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod. 1996;54:197–207. doi: 10.1095/biolreprod54.1.197. [DOI] [PubMed] [Google Scholar]
  • 71.Hovatta O, Silye R, Abir R, Krausz T, Winston RML. Extracellular matrix improves the survival of human primordial and primary fresh and frozen-thawed ovarian follicles in long-term culture. Hum Reprod. 1997;12:1032–1036. doi: 10.1093/humrep/12.5.1032. [DOI] [PubMed] [Google Scholar]
  • 72.Torrance C, Telfer E, Gosden RG. Quantitative study of the development of isolated mouse pre-antral follicles in collagen gel culture. J Reprod Fert. 1989;87:367–374. doi: 10.1530/jrf.0.0870367. [DOI] [PubMed] [Google Scholar]
  • 73.Hulshof SCJ, Figueiredo JR, Beckers JF, Bevers MM, van den Donk JA, van den Hurk R. Effects of fetal bovine serum, FSH and 17β-estradiol on the culture of bovine preantral follicles. Theriogenol. 1995;44:216–226. doi: 10.1016/0093-691x(95)00171-4. [DOI] [PubMed] [Google Scholar]
  • 74.Cain L, Chatterjee S, Collins TJ. In vitro folliculogenesis of rat preantral follicles. Endocrinology. 1995;136:3369–3377. doi: 10.1210/endo.136.8.7628372. [DOI] [PubMed] [Google Scholar]
  • 75.Greenwald GS, Moor RM. Isolation and preliminary characterization of pig primordial follicles. J Reprod Fert. 1989;87:561–571. doi: 10.1530/jrf.0.0870561. [DOI] [PubMed] [Google Scholar]
  • 76.Morbeck DE, Flowers WL, Britt JH. Response of granulosa cells isolated from primary and secondary follicles to FSH, 8-bromo-cAMP and epidermal growth factor in vitro. J Reprod Fertil. 1993;99:577–584. doi: 10.1530/jrf.0.0990577. [DOI] [PubMed] [Google Scholar]
  • 77.Oktay K, Nugent D, Newton H, Selha O, Chatterjee P, Gosden RG. Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertil Steril. 1997;67:481–486. doi: 10.1016/s0015-0282(97)80073-8. [DOI] [PubMed] [Google Scholar]
  • 78.Abir R, Fisch B, Nitke S, Roizman P, Ben Rafael Z: Isolation and culture of human unilaminar and early secondary follicles. Hum Reprod 1988;13 Abstract book 1:0-045, 22
  • 79.Bahadur G, Steele SJ. Ovarian tissue cryopreservation. Hum Reprod. 1996;11:2215–2216. doi: 10.1093/oxfordjournals.humrep.a019079. [DOI] [PubMed] [Google Scholar]
  • 80.Wood CE, Shaw JM. Cryopreservation of ovarian tissue potential “reproductive insurance” for women at risk of early ovarian failure. MJA. 1997;166:366–369. [PubMed] [Google Scholar]
  • 81.Meirow D, Ben Yehuda D, Prus D, Poliack A, Schenker J, Rachmilewitz EA, Lewin A. Ovarian tissue banking in patients with Hodgkin's disease: Is it safe. Fertil Steril. 1998;69:996–998. doi: 10.1016/s0015-0282(98)00093-4. [DOI] [PubMed] [Google Scholar]
  • 82.Oktay K, Newton H, Aubard Y, Salha O, Gosden RG. Cryopreservation of immature human oocytes and ovarian tissue: An emerging technology? Fertil Steril. 1998;69:1–7. doi: 10.1016/s0015-0282(97)00207-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES